AQST — Recent News Coverage
All news mentioning AQST in ESEN's AI-graded feed
News stories with AQST as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on AQST. See /coverage/AQST for the 30-day aggregate.
SEEKINGALPHA.COM
·
2026-08-12
LOW
NEUTRAL
CORR0.35
Aquestive Therapeutics, Inc. (AQST) Q2 2026 Earnings Call Transcript
$AQST
◈ ESEN AI
AQST earnings call transcript publication is a procedural disclosure following Q2 2026 results announcement. As a scheduled earnings call document, this represents routine investor communications rather than new materia…
FINANCE.YAHOO.COM
·
2026-08-12
LOW
NEUTRAL
CORR0.15
Aquestive Therapeutics Q2 Earnings Call Highlights
$AQST
◈ ESEN AI
AQST disclosed Q2 earnings call highlights detailing plans to resubmit a new drug application (NDA) for Anaphylm, an epinephrine sublingual film for type 1 allergic reactions and anaphylaxis. The company expects resubmi…
MANILATIMES.NET
·
2026-08-10
NEUTRAL
BULLISH
CORR0.55
Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (dibutepinephrine) Sublingual Film
$AQST
◈ ESEN AI
AQST announced favorable human factors and pharmacokinetic data for Anaphylm™, a sublingual film formulation of dibutepinephrine intended for anaphylaxis treatment. The company plans to resubmit the New Drug Application…
MANILATIMES.NET
·
2026-07-29
LOW
NEUTRAL
CORR0.15
Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
$AQST
◈ ESEN AI
AQST announced scheduling of its Q2 2026 earnings report and management conference call, a routine disclosure event with limited immediate market catalysts. The announcement itself is procedural in nature, serving prima…
EXPLORE OTHER FILTERS